<br />
<b>Notice</b>:  error_log(): Write of 49 bytes failed with errno=122 Disk quota exceeded in <b>/home/tvrtke/dubrava.com.hr/wp-content/plugins/hummingbird-performance/core/modules/class-page-cache.php</b> on line <b>1982</b><br />
<br />
<b>Notice</b>:  error_log(): Write of 111 bytes failed with errno=122 Disk quota exceeded in <b>/home/tvrtke/dubrava.com.hr/wp-content/plugins/hummingbird-performance/core/modules/class-page-cache.php</b> on line <b>1982</b><br />
{"id":207388,"date":"2026-06-01T13:48:04","date_gmt":"2026-06-01T12:48:04","guid":{"rendered":"https:\/\/dubrava.com.hr\/index.php\/2026\/06\/01\/ogroman-pomak-u-lijecenju-jednog-od-najubojitijih-karcinoma-s-tim-lijekom-se-zivi-gotovo-dvostruko-dulje\/"},"modified":"2026-06-01T13:48:04","modified_gmt":"2026-06-01T12:48:04","slug":"ogroman-pomak-u-lijecenju-jednog-od-najubojitijih-karcinoma-s-tim-lijekom-se-zivi-gotovo-dvostruko-dulje","status":"publish","type":"post","link":"https:\/\/dubrava.com.hr\/index.php\/2026\/06\/01\/ogroman-pomak-u-lijecenju-jednog-od-najubojitijih-karcinoma-s-tim-lijekom-se-zivi-gotovo-dvostruko-dulje\/","title":{"rendered":"Ogroman pomak u lije\u010denju jednog od najubojitijih karcinoma: &#8216;S tim lijekom se \u017eivi gotovo dvostruko dulje&#8217;"},"content":{"rendered":"<p>Pacijenti koji su primali daraxonrasib \u017eivjeli su u prosjeku 13,2 mjeseca, dok je kod onih na kemoterapiji srednje pre\u017eivljenje iznosilo 6,6 mjeseci.<\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.vecernji.hr\/media\/img\/a8\/11\/6296a1d162ccc43be7b8.jpeg\" title=\"Ogroman pomak u lije\u010denju jednog od najubojitijih karcinoma: 'S tim lijekom se \u017eivi gotovo dvostruko dulje'\" \/><\/p>\n<p><a href=\"https:\/\/www.vecernji.hr\/vijesti\/ogroman-pomak-u-lijecenju-jednog-od-najubojitijih-karcinoma-s-tim-lijekom-se-zivi-gotovo-dvostruko-dulje-1965132\" target=\"_blank\" class=\"feedzy-rss-link-icon\">Read More<\/a><\/p>\n<p>Latest &#8211; Ve\u010dernji.hr<\/p><div id=\"dubra-1072224519\" class=\"dubra-after-content dubra-entity-placement\"><a href=\"https:\/\/mr-eko.hr\" aria-label=\"\"><\/a><\/div>","protected":false},"excerpt":{"rendered":"<p>Pacijenti koji su primali daraxonrasib \u017eivjeli su u prosjeku 13,2 mjeseca, dok je kod onih na kemoterapiji srednje pre\u017eivljenje iznosilo 6,6 mjeseci. Read More Latest &#8211; Ve\u010dernji.hr<\/p>\n","protected":false},"author":2,"featured_media":207389,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[30],"tags":[],"class_list":["post-207388","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-vecernji-list"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/dubrava.com.hr\/index.php\/wp-json\/wp\/v2\/posts\/207388","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dubrava.com.hr\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dubrava.com.hr\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dubrava.com.hr\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/dubrava.com.hr\/index.php\/wp-json\/wp\/v2\/comments?post=207388"}],"version-history":[{"count":0,"href":"https:\/\/dubrava.com.hr\/index.php\/wp-json\/wp\/v2\/posts\/207388\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dubrava.com.hr\/index.php\/wp-json\/wp\/v2\/media\/207389"}],"wp:attachment":[{"href":"https:\/\/dubrava.com.hr\/index.php\/wp-json\/wp\/v2\/media?parent=207388"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dubrava.com.hr\/index.php\/wp-json\/wp\/v2\/categories?post=207388"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dubrava.com.hr\/index.php\/wp-json\/wp\/v2\/tags?post=207388"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}